Analysts Set Cardinal Health, Inc. (NYSE:CAH) PT at $251.73

Shares of Cardinal Health, Inc. (NYSE:CAH) have earned an average recommendation of “Moderate Buy” from the eighteen ratings firms that are covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average 12-month price objective among analysts that have covered the stock in the last year is $251.7333.

Several equities analysts recently weighed in on CAH shares. Citigroup increased their price target on shares of Cardinal Health from $245.00 to $265.00 and gave the company a “buy” rating in a research report on Friday. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 4th. William Blair initiated coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating on the stock. Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Finally, Wells Fargo & Company decreased their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research note on Friday, May 1st.

Cardinal Health Trading Up 1.5%

Shares of Cardinal Health stock opened at $232.77 on Friday. The business’s fifty day simple moving average is $221.22 and its 200 day simple moving average is $214.82. The firm has a market capitalization of $54.52 billion, a P/E ratio of 35.59, a price-to-earnings-growth ratio of 1.12 and a beta of 0.49. Cardinal Health has a 12 month low of $137.75 and a 12 month high of $243.21.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the previous year, the firm earned $2.35 earnings per share. The business’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts predict that Cardinal Health will post 10.77 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were paid a $0.5158 dividend. The ex-dividend date was Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.50%.

Institutional Trading of Cardinal Health

A number of large investors have recently bought and sold shares of CAH. Vanguard Group Inc. grew its stake in shares of Cardinal Health by 2.0% during the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after acquiring an additional 617,775 shares during the period. State Street Corp raised its stake in Cardinal Health by 1.8% in the 4th quarter. State Street Corp now owns 12,509,230 shares of the company’s stock valued at $2,570,647,000 after acquiring an additional 221,497 shares during the period. Geode Capital Management LLC lifted its holdings in Cardinal Health by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock valued at $1,336,750,000 after purchasing an additional 43,924 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after purchasing an additional 3,511,579 shares during the last quarter. Finally, Norges Bank bought a new position in Cardinal Health during the fourth quarter worth about $790,344,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.